MD and CA

The Washington Post opens a story this morning with an impartial paragraph (cough, snicker) about Maryland's attempt to fund stem cell research:

“John L. Kellermann III has had Parkinson's disease for 13 years, a condition so debilitating that it forces him to crawl to the bathroom some nights. Yesterday, he urged Maryland lawmakers to pass a $25 million annual initiative to fund embryonic stem cell research that might one day provide a cure for his suffering and that caused by dozens of other diseases.”

The two-page article doesn't mention ethical forms of stem cell research. The article also makes it clear that Maryland is interested in pursuing this avenue because it could make them a leader in that area, which would boost its economy. So we come back to the old cliche: It's all about money.

For those unaware of the validity (and possible superiority) of ethical forms of stem cell research, we recommend this opinion piece from last month's Touchstone.

Eric Scheske

Eric Scheske